01
Professor Carlos Robalo Cordeiro
'Multidisciplinary teams are crucial for the treatment of ILD."
'Multidisciplinary teams are crucial for the treatment of ILD."
'I'm very passionate about unravelling ILD'
'Every country should have a reference centre for ILD'
‘The care and research of ILD is really a joined effort’
'We hope to make the lives of ILD-patients a little more comfortable'
'Meeting fellow-sufferers can mean a lot for ILD-patients'
Acid reflux and idiopathic pulmonary fibrosis: the search for definitive answers
ILD and lung cancer: an unfortunate combination of events
Urgent need for action to prevent ILD caused by marine engines
Non-quartz part of coal might turn the coalminer's lungs to black
‘Lung on a chip’: the solution for testing lung-medicine?
Antifibrotics may help IPF patients waiting for a lung transplantation
IPF: the importance of early identification and a multidisciplinary approach
Sarcoidosis: a riddle to unfold
Improving palliative care for IPF patients
'Protect roadworkers against lung damage from asphalt fumes'
'Support the people that support the patients'
'Why keep smoking when you suffer from a lung disease?'
Why do men suffer from sarcoidosis earlier than women?
IPF: promising new possibilities might offer help with deadly disease
King’s Sarcoidosis Questionnaire translated into Dutch
'Complement IPF guidelines with clinical expertise'
About
BELUNG is an international, online magazine that aims to appear several times a year. It's focused on interstitial lung diseases (ILD), a group of lung diseases that affect the tissue and space around the air sacs of the lungs, the so called interstitium.
BELUNG is for everyone! With BELUNG we want to reach people all across the spectrum. From people that don't know much about ILD, to world leading experts. We strongly believe that by connecting people from different fields, we can do a lot for ILD-patients. All these people can share their experiences about ILD with each other and enlarge each other's knowledge. In short, BELUNG is essential reading for everyone with a personal, professional or other kind of interest in ILD.
While there is a lot of knowledge about other lung diseases (like COPD or asthma), there's not much information to be found on ILD and therefore the awareness of ILD is very low. It can be very beneficial for ILD-patients to create knowledge about their condition. BELUNG aims to create awareness by educating people about a disease that is still a 'big unknown' for so many patients that receive the diagnosis.
Every new edition will be filled with interviews with people who are in some way involved in ILD. From patients and healthcare professionals to patient organizations, governments and family members. Everybody who is involved in ILD is invited to contribute, as sharing information and experiences about the condition is one of the most important objectives of BELUNG. Each issue will also contain articles in which scientific concepts are explained, research findings and comments on the latest news from the world of ILD.
BELUNG Magazine is an initiative of Boehringer Ingelheim, a pharmaceutical company that is actively pursuing knowledge on the cause of interstitial lung diseases that can ultimately be used to develop new treatment options for patients that are affected by this group of diseases.
Nederland
België
Denemarken
Finland
Griekenland
Noorwegen
Zweden
Portugal
Verenigd Koninkrijk